Emalex received FDA authorization for an Expanded Access Program for its investigational Tourette syndrome drug. New Drug ...

Emalex Biosciences’ Expanded Access Programme for investigational Tourette syndrome drug, ecopipam receives US FDA authorization: Chicago Friday, October 10, 2025, 18:00 Hrs [IS ...

Aspartame is considered safe within daily limits, yet researchers are studying whether it may affect tardive dyskinesia. Here ...

Neuromodulatory control of hippocampus-dependent learning is pivotal because dopamine (DA) and norepinephrine (NE) can reconfigure plasticity rules and ...

Nausea and Vomiting Are the Most Frequent Reasons for Discontinuing GLP-1 Therapies, Significantly Impacting Adherence, Titration and Preventing ...

Company's portfolio and pipeline highlight new clinical and real-world data on major depressive disorder and treatment-resistant depression New post-hoc analysis of CAPLYTA® (lumateperone) Phase 3 ...